Article Text

Download PDFPDF

‘They’re creepy creatures with human-like features’: children’s experiences of visual hallucinations in Charles Bonnet syndrome—a qualitative study
  1. Lee Jones1,
  2. Lara Ditzel-Finn2,
  3. Leanne McDonald3,
  4. Mariya Moosajee1,4,5
  1. 1 Institute of Ophthalmology, University College London, London, UK
  2. 2 Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
  3. 3 Department of Psychology, University of West London, London, UK
  4. 4 Moorfields Eye Hospital NHS Foundation Trust, London, UK
  5. 5 The Francis Crick Institute, London, UK
  1. Correspondence to Professor Mariya Moosajee; m.moosajee{at}ucl.ac.uk

Abstract

Objective Charles Bonnet syndrome (CBS) refers to the presence of visual hallucinations occurring secondary to visual impairment. The aim of this study was to understand the phenomenology of CBS in children and assess the emotional impact and support needs of patients and their families.

Design Semistructured qualitative interview study.

Setting UK.

Participants Children (7–15 years) with an inherited retinal disease living with CBS and their parents.

Results 10 participants were recruited from six families (dyadic interviews n=4; parent-only interviews n=2). Thematic analysis identified five superordinate themes relating to experiences of CBS: (1) diagnosis journey, (2) hallucination phenomenology, (3) impact of hallucinations, (4) understanding and managing hallucinations and (5) experiences of support. The impact of CBS was broad and heterogenous, causing significant disruption to patients’ daily life. Limited awareness led to parents expressing largely negative healthcare experiences. Overall, the extent of knowledge and understanding of CBS was an indicator of successful self-management of the condition.

Conclusions The journey towards understanding and managing CBS for both parents and children is challenging. Although coping strategies can lead to improved adjustment, visual hallucinations compounded the difficulty of living with a chronic visual impairment. Healthcare providers have an integral role in ensuring patients and families are effectively supported to allay fears and promote psychological well-being.

  • Child Health
  • Child Psychiatry
  • Mental health
  • Ophthalmology
  • Qualitative research

Data availability statement

No data are available.

https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

WHAT IS ALREADY KNOWN ON THIS TOPIC

  • Charles Bonnet syndrome (CBS) occurs secondary to sight loss.

  • Research into children’s experiences of the condition is sparse, although there are concerns visual hallucinations in this cohort have potential to cause considerable upset/psychological harm.

WHAT THIS STUDY ADDS

  • CBS caused significant disruption to daily life.

  • Limited understanding of the condition among the public and healthcare professionals hinders appropriate clinical management decisions, such as referral to CBS patient support.

  • Receiving an accurate diagnosis was reassuring for patients and their families and led to improved psychological adjustment.

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

  • Increased awareness of CBS occurring across all ages is necessary to ensure patients and families are equipped to live well with the condition.

Introduction

Charles Bonnet syndrome (CBS) is a condition where visual hallucinations occur secondary to visual impairment (VI). The underlying pathophysiology is generally considered to be deafferentation, whereby cortical hyperexcitability following reduced input to the visual cortex causes spontaneous visual hallucinations.1 Typical phenomenology includes transient episodes of simple or complex hallucinations that are purely visual, with no other affected modalities. Simple hallucinations consist of geometric shapes and patterns (ie, tessellopsia), colours, lights and flashes (ie, photopsia), whereas complex hallucinations involve formed images including people, animals and vivid scenery.2 3 Prevalence of CBS has been estimated at 10–20% of adults with VI4; however, these estimates vary widely.5 6 Individuals with more advanced vision loss have an elevated risk7; however, the condition also occurs in patients with largely preserved vision.8 9

Despite patients of any age being at risk, most research has been directed towards older adults. This may be explained by age being a risk factor for many sight-threatening conditions. Yet, a small number of studies describe the phenomena occurring in children and adolescents, reporting the clinical profiles of those affected.10–12 These studies provide initial insights into CBS in young people, however, are limited in elucidating patients’ experience of the condition. This is significant given that CBS in adults may cause considerable anxiety and distress.13 For example, hallucinations are often macabre, such as faces with a grotesque or distorted appearance (ie, prosopometamorphopsia) or include ominous cloaked or uniformed figures.14 Retaining an understanding that visual hallucinations are not real can have a protective effect on psychological well-being; however, children may have a tendency to believe their hallucinations are real,15 suggesting this cohort may be more susceptible to maladaptive responses to hallucinations, such as fear and distress.

Understanding young people’s experiences of CBS is essential to enable clinical and research priorities to be mapped against the needs of patients and their families. The aim of this study was to explore the experience of CBS from the perspectives of children and their families, including hallucination phenomenology, emotional impact and accessing support.

Methods

The study used semistructured interviews with parent and/or children with CBS. All parents and children were told about the study aims and provided written consent to take part. The study was designed and reported following the guidance of the Consolidated Criteria for Reporting Qualitative Research.16

Purposive sampling was used, whereby participants were recruited from Moorfields Eye Hospital and Esme’s Umbrella, a charity for people living with CBS. Eligible participants were between the ages of 5 and 16 years and diagnosed with CBS. Recruitment advertisements were published via social media and participants were screened for CBS via a detailed patient history prior to inclusion. Dyadic interviews were conducted online, where the child and parent were interviewed together. The topic guide was developed with input from Esme’s Umbrella. Interviews were conducted by a female specialising in child and adolescent health psychology (LD-F), with a personal interest in CBS and no prior relationship with participants. Six families were recruited with 10 participants interviewed (dyadic interviews n=4; parent-only interviews n=2). No participants withdrew from the study. Parent-only interviews were conducted as requested by participants. A summary of participant demographics is provided in online supplemental table 1.

Average interview duration was 40 min. Audio-recorded interviews were transcribed verbatim. Transcripts were analysed using thematic analysis,17 whereby texts were read and meaningful units were coded. Data were coded by two researchers (LJ, LM) and discussed among the entire research team. Data saturation was defined as when no new information was coded during transcript analysis, indicating further data collection or analysis was unnecessary. After coding, themes were generated by identifying patterns across interviews and collecting relevant codes together. Themes were created inductively (ie, driven by the content of the data) due to the limited previous research in the area, and therefore no specific theories were used to generate themes. Data were analysed using NVivo V.13 (QSR International, Cambridge, Massachusetts, USA).

Results

Average age of the children at the time of interview was 11±2.9 years. Five patients were diagnosed with an inherited retinal dystrophy (IRD) and one with a hereditary optic neuropathy. IRDs are a group of genetically and phenotypically heterogenous conditions affecting 1:1000 people worldwide.18 Analysis revealed five superordinate themes related to experiences of CBS: (1) diagnosis journey, (2) hallucination phenomenology, (3) impact of hallucinations, (4) understanding and managing hallucinations and (5) experiences of support.

Theme 1: diagnosis journey

A common theme was the widespread lack of awareness about CBS among both parents and healthcare professionals. Parents described how they were initially unaware of CBS prior to their child receiving a diagnosis. Many parents initially dismissed their child’s visual hallucinations as imaginary friends or typical childhood experiences. When reporting symptoms to clinicians, participants encountered a similar lack of awareness, which became a source of frustration. Even where professionals recognised the symptoms of CBS, there was uncertainty and caution applying a definitive diagnosis. This led parents to prioritise their own research, seeking information online to better understand the condition. Once aware, this largely alleviated concerns and normalised the condition. Limited awareness of CBS resulted in delays in receiving an accurate diagnosis, leaving parents feeling unsupported despite their proactive efforts to educate themselves. Diagnosis journey subthemes and example participant quotes are provided in table 1.

Table 1

Diagnosis journey subthemes with participant quotes

Theme 2: hallucination phenomenology

Children reported both simple and complex hallucinations as part of their experiences. Simple hallucinations were typically colourful shapes, although descriptions varied among participants. One participant described experiencing only complex hallucinations, whereas they had previously encountered simple ones, suggesting the nature of their hallucinations had changed over time. This participant attributed this change to a deterioration in their vision, a belief echoed by others in the study. Complex hallucinations were frequently described as scary or frightening, taking the form of figures or entities. In some instances, these hallucinations resembled recognisable characters, but with distortions that rendered them distressing. Additionally, many participants reported hallucinations involving insects, such as spiders, flies and wasps. Hallucination phenomenology subthemes and example participant quotes are provided in table 2.

Table 2

Hallucination phenomenology subthemes with participant quotes

Theme 3: impact of hallucinations

CBS had a profound and multifaceted impact on day-to-day life, affecting emotional, social and physical well-being. Children experienced a range of emotions, with fear being the most frequent, often linked to the distressing nature of the hallucinations and the unpredictability of their onset. Agitation sometimes prevented children from feeling comfortable enough to return to locations where they had previously encountered hallucinations. One parent explained how their child felt unable to visit a grandparent’s house due to such fears. Emotional responses varied depending on the nature of the hallucinations, including their proximity and content. For most, CBS caused significant issues with sleeping and bedtime. While school life was generally not affected, one participant reported hallucinations interfered with their ability to complete schoolwork. Hallucinations compromised physical safety, with participants feeling more prone to falls, accidents or risky behaviours due to their vision being obscured or their fear of the images. In some cases, this led participants to avoid certain activities altogether, which in turn resulted in isolation from social networks. One participant expressed difficulties explaining CBS to friends, further highlighting the social challenges posed by the condition. Impact of hallucination subthemes and example participant quotes are provided in table 3.

Table 3

Impact of hallucination subthemes with participant quotes

Theme 4: understanding and managing hallucinations

Several potential triggers were reported, including low lighting, stress and stimuli from the physical environment. Among these, low lighting—particularly at night—was the most common. Participants described how hallucinations could emerge from around corners, such as doors and doorframes. One participant shared a strategy of changing the physical environment, such as closing doors to avoid potentially triggering situations. Stress was widely regarded as a contributing factor, with participants developing strategies to manage their symptoms. Strategies included making changes to their physical surroundings and using head or eye movements to disrupt or displace the hallucinations. Participants reported success with several coping mechanisms, including self-regulation techniques like breathing exercises and self-soothing behaviours. A common approach was to remind themselves that the hallucinations were not real. Even among younger participants, maintaining insight was a crucial factor in managing anxiety. Understanding and managing hallucination subthemes and example participant quotes are provided in table 4.

Table 4

Understanding and managing hallucination subthemes with participant quotes

Theme 5: experiences of support

Parents generally agreed that their families had not been sufficiently supported. In addition to the perceived lack of knowledge among clinicians, the information provided often failed to meet their expectations or answer their specific questions. Some participants highlighted the value of accessing specialist support services, such as Esme’s Umbrella, which offered an understanding of CBS. Despite this, there was a desire for enhanced support systems, such as peer support. However, participants reported difficulties in finding other young people with lived experience of the condition. Overall, there was a shared desire among participants to assist others with CBS, with the hope that participating in research would raise awareness about the need for improved support pathways and more effective management strategies to help future patients. Experiences of support subthemes and example participant quotes are provided in table 5.

Table 5

Experiences of support subthemes with participant quotes

Discussion

This qualitative study provides an in-depth exploration of children and their families’ experience of living with CBS. Overall, participants described mostly negative experiences, where hallucinations had caused considerable upset with long-standing residual effects. Perspectives on the quality of healthcare and support that had been received were largely considered suboptimal.

Although hallucinations have previously been researched in children with clinical history, such as schizophrenia,19 and emotional disorders,20 little is known about CBS among children. Studies have identified that children experience distress and impaired functioning as a consequence of hallucinators; however, research has generally focused on auditory hallucinations, such as hearing voices.21 Few studies address visual hallucinations in children; however, among these, there is consensus that visual hallucinations evoke anxiety.12 Previous research suggests complex hallucinations have a strong influence on children’s mental health, significantly affecting levels of depression, anxiety and dissociation.22 Families in our study described a significant negative impact of CBS, suggesting more efforts are needed to facilitate a shared understanding of young people’s experience, which can help inform the development, implementation and evaluation of support pathways to improve healthcare services.

Recent recommendations outline the clinical management for patients with visual hallucinations in high-burden areas, including CBS.23 The consensus framework was developed following the Study of Hallucinations in Parkinson’s Disease, Eye Disease and Dementia (SHAPED) trial, which suggests management should begin prior to the onset of hallucinations, through routine provision of information at the time of consultation, informing patients of their susceptibility, and pre-emptive questioning to encourage reporting. Participants in our study reported being unaware of CBS prior to symptoms presenting, and expressed frustration at the lack of information they were provided. These findings align with others demonstrating low awareness of CBS among patients and healthcare professionals, particularly those with less specialist experience in ophthalmology.24 25 Despite recommendations to forewarn patients, the extent to which these conversations are facilitated in practice is unclear. Taking together our findings and the SHAPED recommendations,23 ophthalmologists, paediatricians and all those working with children diagnosed with progressive or severe sight loss should be encouraged to ask and inform patients about visual hallucinations.

Superficial commonalities in the phenomenology of CBS between adults and young people should not obscure potentially significant differences between these groups. For example, clinically significant CBS, in other words, patients who experience distress despite reassurance, accounts for around one-third of all cases.14 Yet, all families in this study reported experiencing distressing hallucinations. In that respect, children may be more susceptible to clinically significant CBS, imposing a negative effect on psychological well-being. This may be compounded by younger people having a diminished ability to distinguish between hallucinations and real life15; however, participants in this study generally recognised hallucinations from reality. These findings represent diagnostic challenges in CBS case ascertainment among children. For example, CBS may be confused with childhood imaginings, and children may have difficulties describing their symptoms.15 Imaginary friends are common among children but differ from visual hallucinations, such as they are often invoked by the child at will and typically function as a play partner associated with positive emotions.26 A further challenge is that visual hallucinations have a broad differential diagnosis and may initially be investigated as schizophrenia/schizoaffective disorder, migraines, seizures or tumours.27

Our results provide qualitative details regarding ophthalmological associations in CBS. Previous studies report better eye visual acuity of Snellen 6/18 or worse as a threshold for increased risk of CBS.7 Similar studies suggest CBS occurs more frequently among groups with more extensive VI.28–30 A participant in our study reported changes in the phenomenology of their hallucinations corresponding to the worsening of their blind spot (ie, visual field scotoma). The participants explained: ‘over the years since my blind spot is growing more and more, it’s growing as well as I get older. The hallucinations have been rapidly increasing in times it has been appearing.’ This finding supports an association between the degree of VI and CBS. Yet, visual acuity is not an accurate metric to inform CBS risk as signals from the eye can be reduced without impacting acuity.31 Our previous work has identified CBS in children with low vision in one eye but normal vision in the contralateral eye, as well as in those with non-progressive congenital eye defects.12 Several studies have concluded that poor visual acuity is not a primary risk factor for CBS.8 9 Other theories suggest hallucination content reflects the functional specialisation of the activated region of the brain. For example, hallucinations of colours, faces, textures and objects correlate with cerebral activity in the ventral extrastriate visual cortex. Specifically, textures such as brickwork are linked with activity around the collateral sulcus and hallucinations of faces and objects are associated with activity in the left middle fusiform gyrus and right middle fusiform gyrus, respectively.32

Several potential triggers were reported including low lighting, specific stimuli and stress. Visual hallucinations occur predominantly under low-lighting conditions as brightness aids object perception, while darkness removes cues to activate scene representation. Research in Parkinson’s disease identifies ambient lighting as an important factor for the onset of visual hallucinations.33 The specific role of lighting in CBS remains unclear as patients report experiencing hallucinations in bright light, dim light and darkness. Participants described how seemingly mundane and innocuous stimuli could lead to distressing hallucinations, such as laundry resting on hangers becoming ghost-like figures, and faces emerging in gift wrapping paper. These examples could be explained by visual perception theories which implicate impaired attentional binding and poor sensory activation of an object, biasing perceptions to allow the intrusion of a hallucinatory object into a scene perception.34 These stimuli may be perceived as triggers as once an image is hallucinated, it may become associated with a specific hallucinatory scene representation, increasing the probability of the same image being triggered again and may account for the repetition of specific images.34 Stress was widely believed to be a contributing factor, and studies suggest stressful life events, such as natural disasters and pandemics, may trigger more clinically significant CBS.35 36 Parents were worried about their child’s mental health and often strived to minimise stress to reduce hallucinations. Anxiety symptoms and disorders are common problems associated with patients with ophthalmic disease, including child and adolescent patients.37 Notably, patients with CBS report worse scores on measures of anxiety, depression and social dysfunction when compared with patients with VI without CBS,38 suggesting children with CBS are at an elevated risk of experiencing mental health problems.

A range of management strategies were described, including changes to the physical environment, such as increasing room brightness, and practising specific head or eye movements, or repetitive blinking. Anecdotal evidence suggests these ‘brain shunting’ exercises can be effective in disrupting CBS.39 These behavioural strategies can be recommended to all patients to equip them with skills to mitigate the impact of visual hallucinations, although more research is required to establish a robust evidence base to better understand their therapeutic effects. In cases where CBS causes significant distress, referral to child psychiatry for formal assessment and management may be required. Psychological therapies such as cognitive–behavioural therapy or pharmacological treatment may provide relief,40 though a robust evidence base regarding the long-term efficacy in both children and adults is lacking.

This study is limited in that a small number of families were interviewed and they were all based in the UK, which may restrict the transferability of our findings. Moreover, our use of parent–child dyadic interviews is arguably a limitation as this may have influenced responses through social desirability; yet, we believe this was also a strength as it encouraged expression among the children which increased the richness of the data.

In summary, our results provide new evidence relating to children’s experiences of CBS, and visual hallucinations more broadly. These reflections draw attention to priority areas for clinical service improvements, such as greater knowledge and awareness and better signposting to support. Despite the availability of online resources, most felt they had not been provided with sufficient support and information, resulting in participants doing their own research. The research team have worked with Esme’s Umbrella to provide an online resource with information about CBS targeted towards children and young people (www.charlesbonnetsyndrome.uk/children-young-people). An increased understanding of CBS appeared to be an indicator of better adjustment and psychological health outcomes; thus, screening children and young people to obtain the relevant history about CBS has potential to yield large benefits for patients and their families.

Data availability statement

No data are available.

Ethics statements

Patient consent for publication

Ethics approval

This study involves human participants and was approved by the London–Fulham Research Ethics Committee (ID: 21/PR/0693). Participants gave informed consent to participate in the study before taking part.

Acknowledgments

The authors would like to thanks Judith Potts at Esme's Umbrella for her assistance with this study.

References

Footnotes

  • X @jones_lee1

  • Contributors LJ and MM conceived and designed the study. LJ and LD-F collected the data. LJ, LD-F and LM analysed the data, which were agreed by all authors. LJ wrote the manuscript and all authors contributed to reviewing and editing. All authors approved the final version. MM is the guarantor.

  • Funding This work was supported by Thomas Pocklington Trust, Wellcome Trust (205174/Z/16/Z), and the National Institute for Health and Care Research (NIHR), Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.